en
{{ Suche }}
Midas Worldwide
Please note

The offer on this page is aimed exclusively at business customers.

Intermediates for Pharma

Midas Pharma is providing products and product related services in the fields of intermediates and Starting Materials for APIs (Active Pharmaceutical Ingredients). A global network and many years of experience enabled us to build up resilient supply chains which are in compliance with contemporary quality and environmental standards. Our products are supported by state-of-the-art regulatory documentation customized to your needs thus enabling a smooth approval by health authorities.

Featured Products

139306-10-8

(S)-3-[1-(Di­methyl­amino)-ethyl]-phenol

898543-06-1

4-{4-[(5S)-5-(Amino­methyl)-2-oxo-1,3-oxa­zolidin-3-yl]-phenyl}-morpholin-3-one hydro­chloride

24065-33-6

5-Chloro-2-thiophenecarboxylic acid

Working with Midas Pharma means:

  • More than 30 years of experience and networking in the pharma industry
  • Full coverage of regulatory aspects
  • Full QM (Quality Management) support
  • Securing, upgrading & derisking critical supply chains
  • CLP (Classification, Labeling & Packaging) & REACh (Registration, Evaluation, Authorisation and Restriction of Chemicals) compliance
  • Import & transportation of dangerous goods
  • Warehousing

  • Strategy for defending and justifying complex starting materials towards Health Authorities

    • Impurities (M7, Q3A, nitrosamines) carry-over and risk-assessment
    • CMC documents compilation
    • Regulatory/QM support during filing/ Lifecycle Management
    • Fall-back plan


    Intermediates with ICH Q11 compliant documents

    Regulatory Complexity Intermediates for Biopharma

    • Internal database with over 10k starting materials and intermediates entries
    • Technology database supporting the identification of the right CDMO for your product

    Is your process still state of the art and/or competitive? We are experienced in offering a customized solution.

  • Challenges of old supply chains:

    • Documents & processes are no longer state of the art
    • Importance and interest of the concerned substance may change to the supplier 
    • Changes always trigger immense internal capacities

    Advantages of an up-to-date/improved supply chain:

    • De-risking shortage risks
    • Availability of upgraded documentation → possible extention to other markets & products

    We offer you a full-service package including technical, regulatory affairs and qualification support customized to your requirements sharing the load of your internal work.

Overview Intermediates for Pharma

Find your Product

2749-11-3

L-(+)-Alaninol

149690-12-0

(2R,4S)-4-Amino-5-(biphenyl-4-yl)-2-methyl­pentanoic acid ethyl ester hydro­chloride

5856-62-2

(S)-(+)-2-Amino-1-butanol

2958-36-3

2-Amino-2',5-dichlorobenzophenone

22889-78-7

4-Amino-3,5-di­chloro­pyridine

155899-66-4

(3aR,4S,6R,6aS)-6-Amino-2,2-di­methyl­tetra­hydro-3aH-cyclo­penta[d][1,3]di­oxol-4-ol

35303-76-5

4-(2-Amino­ethyl)benzyl­sulfon­amide

62-57-7

2-Amino­iso­butyric acid

7252-84-8

3-Amino-6-methoxy­pyridazine

898543-06-1

4-{4-[(5S)-5-(Amino­methyl)-2-oxo-1,3-oxa­zolidin-3-yl]-phenyl}-morpholin-3-one hydro­chloride

85006-31-1

3-Amino-4-methyl-2-thio­phene ­carboxylic acid methyl ester

391901-45-4

(1R)-2-[[2-(4-Amino­phenyl)­ethyl]­amino]-1-phenyl­ethanol

438056-69-0

4-(4-Aminophenyl)-3-morpholinone

112101-81-2

5-[(2R)-2-Amino­propyl]-2-methoxy­benzene­sulfon­amide

29676-71-9

2-(2-Amino-4-thiazol­yl)-acetic acid

63-05-8

4-Andro­stene-3,17-di­one

125971-95-1

Atorva­statin acetonide tert-butyl ester

94094-72-1

Benethamine diacetate

817204-32-3

(2'R)-N-Benzoyl-2'-deoxy-2'-fluoro-2'-methylcytidine-3',5'-dibenzoate

71258-18-9

1-Benzyl-4-cyano-4-phenyl­piperidin hydro­chloride

1062580-52-2

(3R,4R)-1-Benzyl-N,4-di­methyl­piperidin-3-amine hydro­chloride

477600-73-0

N-[(3R,4R)-1-Benzyl-4-methyl­piperidin-3-yl]-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

204589-80-0

3-[2-(4-Benzyl­oxy­phenyl)-1-(4-fluoro­phenyl)-4-oxo-azetidin-3-yl]-propionic acid methyl ester

1369773-39-6

(2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)-amino]-2-methylpentanoic acid

1012341-50-2

(2R,4S)-5-(Bi­phenyl-4-yl)-4-[(tert-butoxy­carbonyl)amino]-2-methyl­pentanoic acid

477600-71-8

(2R,3R)-2,3-Bis[(4-methyl­benzoyl)oxy]butan­dioic acid / (3R,4R)-N,4-di­methyl-1-(phenyl­methyl)-3-piperidin­amine

2061897-68-3

Boc-His(Trt)-Aib-OH

373-61-5

Boron tri­fluoride acetic acid complex

109-63-7

Boron tri­fluoride diethyl ether complex

373-57-9

Boron tri­fluoride methanol complex

462-34-0

Boron tri­fluoride tetra­hydro­furan complex

112704-79-7

4-Bromo-2-fluoro­benzoic acid

20826-04-4

5-Bromo­nicotinic acid

146533-41-7

5-(4-Bromo­phenyl)-4,6-dichloro­pyrimidine

1118767-16-0

tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu

57260-71-6

N-tert-Butoxy­carbonyl­piperazine

927-74-2

3-Butyn-1-ol

976-71-6

Can­renone

82717-96-2

N-(1-S-Carb­ethoxy-3-phenyl­propyl)-S-alanine

2224-52-4

N-Carboxy-L-alanine anhydride

181289-15-6

3-(Carboyl­methyl)-5-methyl­hexanoic acid

90-99-3

Chlorodiphenylmethane

59469-29-3

7-Chloro-5-(2-fluoro­phenyl)-2,3-di­hydro-1H-[1,4]benzo­di­azepine-2-methan­amine di­maleate

92-39-7

2-Chloro­pheno­thiazine

1228780-72-0

1-{[2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazine dihydrochloride salt

627-30-5

3-Chloro-1-propanol

3680-69-1

4-Chloro­pyrrolo[2,3-d]pyrimidine

24065-33-6

5-Chloro-2-thiophenecarboxylic acid

80-15-9

Cumene hydroperoxide

125971-94-0

(4R,6R)-6-(Cyano­methyl)-2,2-di­methyl-1,3-di­oxan-4-yl-acetic acid 1,1-di­methyl ethyl ester

294-90-6

Cyclen

53-43-0

De­hydro­epi­andro­sterone

853-23-6

De­hydro­epi­andro­sterone acetate

863329-66-2

(2'R)-2'-Deoxy-2'-fluoro-2'-methyluridine

145783-14-8

4,6-Di­chloro-5-nitro-2-(propyl­thio)-pyrimidine

145783-15-9

4,6-Di­chloro-2-(propyl­sulfanyl)-pyrimidin-5-amine

85118-00-9

2,6-Di­fluoro­benzyl bromide

376608-71-8

(1R,2S)-2-(3,4-Di­fluoro­phenyl)-cyclo­propan-1-amine / (2R)-2-Hydroxy-2-phenyl­acetic acid

1156491-10-9

(1R,2S)-rel-2-(3,4-Di­fluoro­phenyl)-cyclo­propan­amine hydro­chloride

139306-10-8

(S)-3-[1-(Di­methyl­amino)-ethyl]-phenol

131466-61-0

(3R)-3-[[(1,1-Di­methyl­ethyl)di­methyl­silyl]oxy]glutaric acid 1-[(R)-carboxy­methyl] ester

481-29-8

Epi­andro­sterone

119665-62-2

9-[O-(1-Ethoxy-1-methyl­ethyl)-oxime]-6-O-methyl-2',4''-bis-O-(trimethyl­silyl)-erythro­mycine

27143-07-3

Ethyl­chloro[(4-methoxy­phenyl)-hydrazono] acetate

359878-47-0

N-(4-Fluoro­benzyl)-1-methyl­piperidine-4-amine

125971-96-2

4-Fluoro-α-(2-methyl-1-oxo­propyl)-τ-oxo-N,β-di­phenyl­benzyl­butan­amide

163222-32-0

(3R,4S)-1-(4-Fluoro­phenyl)-3-[(3S)-3-(4-fluoro­phenyl)-3-hydroxy­propyl]-4-(4-phenyl­methoxy)-phenyl]-2-azetidin­one

147118-37-4

N-[4-(4-Fluoro­phenyl)-5-formyl-6-iso­propyl-2-pyrimidinyl]-N-methyl­methane­sulfon­amide

147118-36-3

N-[4-(4-Fluoro­phenyl)-5-(hydroxy­methyl)-6-iso­propyl-2-pyrimidinyl]-N-methyl­methan­sulfon­amide

355806-00-7

(3R,5S,6E)-7-[4-(4-Fluoro­phenyl)-6-iso­propyl-2-[(methane­sulfonyl)methyl­amino]pyrimidin-5-yl]-3,5-di­hydroxy­hept-6-enoic acid tert-butyl ester

999-97-3

1,1,1,3,3,3-Hexa­methyl­disilazane

3190-71-4

H-Glu(OBzl)-NCA

302-01-2

Hydrazine

1076-38-6

4-Hydroxy­coumarine

90315-82-5

(R)-(-)-2-Hydroxy-4-phenyl­butyric acid ethyl ester

3415-08-5

(S)-4-[(4-Hydroxy­phenyl)-methyl]-2,5-oxa­zolidine­dione

25333-42-0

(R)-(-)-3-Hydroxy­quinuclidine

1334513-02-8

(S)-Isopropyl 2-(((S)-(perfluorophenoxy)-(phenoxy)-phosphoryl)-amino)-propanoate

143782-23-4

4-Iso­thio­cyanato-2-(tri­fluoro­methyl)-benzonitrile

42267-27-6

L-Lys(TFA)-NCA

6284-40-8

Meglumine

5486-79-3

3-Methoxy-O,α-di­methyl-L-tyrosin hydro­chloride

147118-35-2

Methyl(3R)-3-(tert-butyl­di­methyl­silyl­oxy)-5-oxo-6-tri­phenyl­phosphoran­yliden hexan­oate

1778-09-2

4’-(Methyl­mercapto)-aceto­phenone

3446-89-7

4-(Methyl­mercapto)-benz­aldehyde

13532-18-8

3-(Methyl­mercapto)-propionic acid

625120-81-2

N-Methyl-N-pentyl-β-alanine hydro­chloride

955997-89-4

4-(2-Methyl­propoxy)benzyl­methan­amin acetate

1235865-75-4

Methyl 2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-4-fluorobenzoate

503615-03-0

3-(4-Morpho­linyl)-1-(4-nitro­phenyl)-5,6-di­hydro-2(1H)-pyridin­one

161596-47-0

(2S)-N-(Oxiranylmethyl)-phthalimide

446292-08-6

2-{{(5S)-2-Oxo-3-[4-(3-oxomorpholin-4-yl)-phenyl]-1,3-oxazolidin-5-yl}-methyl}-1H-isoindole-1,3-dione

52-67-5

D-Penicill­amine

770-12-7

Phenyl­phosphoryl di­chloride

463-49-0

1,2-Propa­diene

1383385-64-5

N-(2-Pyridyl)-4-(4,4,5,5-tetra­methyl-1,3,2-dioxa­borolan-2-yl)benz­amide

128013-69-4

rac-Pre­gabalin

147118-40-9

Rosuvastatin methyl ester

32384-65-9

2,3,4,6-Tetra-O-(tri­methyl­silyl)-D-glucono-1,5-lactone

421-50-1

1,1,1-Tri­fluoro-2-propanone

2752-19-4

Tris[[1.1e-bi­phenyl]-2-oxy]phosphine

You did not find what you were looking for?

Talk to us – our website does not show our entire portfolio.
We will be happy to inform you about further offers!

Your Contact

Dr. Danielle Leone-Stumpf

Dr. Danielle Leone-Stumpf

International Division
Senior Director Intermediates for Pharma & Biopharma

Midas Pharma GmbH
Rheinstr. 49
55218 Ingelheim
Germany
Send E-Mail

Products

Intermediates for Biopharma

Learn more

Chemicals

Learn more

Drug Substances (APIs)

Learn more

Share this page